Isis Pharmaceuticals, Inc. (ISIS) Posts Mixed Q4 Results
Tweet
Share
E-mailGet Alerts ISIS Hot Sheet
Price: $57.56 --0%
Financial Fact:
Diluted net loss (in dollars per share): 0.06
Today's EPS Names:
RZLT, USAU, ESP, More
Financial Fact:
Diluted net loss (in dollars per share): 0.06
Today's EPS Names:
RZLT, USAU, ESP, More
Join SI Premium – FREE
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q4 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $32.4 million versus the consensus estimate of $30.3 million.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- JPMorgan Upgrades Graphic Packaging Holding Company (GPK) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
